From international reference price analysis through to list to net pricing we can support your pricing needs.
Commercial Success
We’ve got the tools needed to succeed
We have a range of tools that can help you determine the pricing dynamics of your products to optimize their list and net price
We can provide the pricing analysis and guidance to support pricing certificate requirements
We can analyse your list to net pricing calculations across the globe to inform your pricing strategy
Dissecting the First EU JCA
The first EU Joint Clinical Assessment (JCA) has now been published, but with so many perspectives already in the market, the real question is: what does it actually mean for your next submission?
Rather than revisiting the theory, this webinar focuses on key strategic signals revealed by the first JCA. Using the assessment of tovorafenib as a case study, we will examine what happened in practice and explore the implications for manufacturers preparing upcoming submissions.
Hosted by Paul Craddy, Charlie Hewitt & Lauren Boland
